Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Agnes Zopf"'
Autor:
Agnes Zopf, Roman Raim, Martin Danzer, Norbert Niklas, Rita Spilka, Johannes Pröll, Christian Gabriel, Andreas Nechansky, Markus Roucka
Publikováno v:
BioTechniques, Vol 58, Iss 3, Pp 126-134 (2015)
The detection of KRAS mutations in codons 12 and 13 is critical for anti-EGFR therapy strategies; however, only those methodologies with high sensitivity, specificity, and accuracy as well as the best cost and turnaround balance are suitable for rout
Externí odkaz:
https://doaj.org/article/48ce54324e2547dcbfd7102c04485ccc
Autor:
Birgit Lohberger, Beate Rinner, Norbert Niklas, Bernadette Liegl-Atzwanger, Andreas Leithner, Carina Fischer, Agnes Zopf, Alexander Deutsch, Mette Jorgensen, Christian Gabriel, Elke Verena Froehlich, Susanne Scheipl
Publikováno v:
Journal of Cancer
Background: Chordoma is a rare primary malignant bone tumour. Treatment options are mainly restricted to surgical excision, since chordomas are largely resistant to conventional ionising radiation and chemotherapy. Thus, there is a strong need to gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b54e92bbd819f368a2572977831aed
http://europepmc.org/articles/PMC4565847
http://europepmc.org/articles/PMC4565847
Autor:
R. Kastner, Johannes Pröll, Pierre Foskett, Norbert Niklas, S Preuner, Peter Valent, Thomas Lion, Agnes Zopf, Christian Gabriel
Publikováno v:
European Journal of Cancer. 50:793-800
An emerging problem in patients with Philadelphia (Ph)-positive leukaemias is the occurrence of cells with multiple mutations in the BCR-ABL1 tyrosine kinase domain (TKD) associated with high resistance to different tyrosine kinase inhibitors. Rapid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391af910810ec0496c229950e4da6527
https://doi.org/10.1016/j.ejca.2013.11.030
https://doi.org/10.1016/j.ejca.2013.11.030
Autor:
Rita Spilka, Norbert Niklas, Martin Danzer, Christian Gabriel, Johannes Pröll, Andreas Nechansky, Markus Roucka, Agnes Zopf, Roman Raim
Publikováno v:
BioTechniques. 58(3)
The detection of KRAS mutations in codons 12 and 13 is critical for anti-EGFR therapy strategies; however, only those methodologies with high sensitivity, specificity, and accuracy as well as the best cost and turnaround balance are suitable for rout
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75db31e5b928fcf1a8b5dd601c14f1a8
https://pubmed.ncbi.nlm.nih.gov/25757545
https://pubmed.ncbi.nlm.nih.gov/25757545
Autor:
Norbert Niklas, Agnes Zopf, Johannes Weinberger, Johannes Pröll, Konstantin Krismer, Christian Gabriel, Peter Bettelheim, Karin Wiesinger
Publikováno v:
Cellular immunology. 288(1-2)
Diversity of B and T cell receptors, achieved by gene recombination and somatic hypermutation, allows the immune system for recognition and targeted reaction against various threats. Next-generation sequencing for assessment of a cell’s gene compos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef20959f41363635f64605133766dc37
https://pubmed.ncbi.nlm.nih.gov/24607567
https://pubmed.ncbi.nlm.nih.gov/24607567
Autor:
Helene Polin, Johannes Pröll, Katja Hofer, U. Heilinger, Agnes Zopf, Martin Danzer, Christian Gabriel
Publikováno v:
Vox sanguinis. 95(2)
Background and Objective Genotyping may be applied for rare blood group polymorphisms in a high-throughput mode as well for the molecular determination of blood groups due to unclear serological results. Material and Methods We developed and validate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89da2165a44d55ce0af96010678dd850
https://pubmed.ncbi.nlm.nih.gov/18510579
https://pubmed.ncbi.nlm.nih.gov/18510579
Autor:
Thomas Lion, Agnes Zopf, Pierre Foskett, Renate Kastner, Sandra Preuner, Proell Johannes, Peter Valent, Christian Gabriel
Publikováno v:
Blood. 122:1373-1373
Mutations in the BCR-ABL1 tyrosine kinase domain (TKD) are regarded as the most important mechanism of resistance to tyrosine kinase inhibitors (TKIs) in patients with Ph-positive leukemias. The occurrence of two or more mutations on the same DNA mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ba528611a00f5d742e675e27eef6327
https://doi.org/10.1182/blood.v122.21.1373.1373
https://doi.org/10.1182/blood.v122.21.1373.1373